Hide Board Information

Show Board Information

Kane Biotech Inc. KNBIF

Board Mod: Add me as mod

Asst Mods:

Last Post: 03/10/2014 9:25:47 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 1

Kane Biotech Inc. (OTCMRKTS: KNBIF) Stock Message Board

1. KNBIF Company Profile

    

2. KNBIF Time & Sales

    

3. KNBIF Recent News

    

4. KNBIF Filings

    

5. KNBIF Financials

    

6. KNBIF Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

3	Latest Kane Biotech (KNBIF) Headlines Kane	Stock_Tracker	03/10/2014 9:25:47 AM
2	KNBIF 0.09 Stock Charts $KNBIF 1 Month Chart	chartguy89	03/08/2014 4:06:17 AM
1	KNBIF Stock Charts Last: UNCH Thursday, February	chartguy89	02/27/2014 11:02:34 AM

Recent Articles

• Celebrating Janeen Norquist: A Trailblazer in the Trades
• David Black Takes Helm as CFO at Malibu Boats, Inc.
• TGE Expands Portfolio with Strategic Hotel Acquisition in Asia
• Hydro One's Recent Quarter Results Highlight Economic Growth
• OrthoPediatrics Introduces Innovative Pediatric Bracing Solutions
• Chicago Atlantic BDC, Inc. Announces Q4 2025 Cash Dividend Details
• KP Tissue Reports Strong Q3 2025 Financial Performance
• Century Therapeutics Launches Innovative Solution for Diabetes Management
• Adagene and Third Arc Bio Partner for Innovative Cancer Solutions
• Aebi Schmidt Group Reports Growth in Profitability After Shyft Merge
• Insights into Recent Transactions by Aspo Plc’s Board Member
• Prosafe SE Reports Significant Shareholding Changes
• Chicago Atlantic BDC, Inc. Unveils Impressive Q3 2025 Results
• KP Tissue Unveils Quarterly Dividend of $0.18 for Shareholders
• Shell's Latest Prospectus Supplement Overview and Insights
• Dillard's, Inc. Sees Growth in Q3 Performance Metrics
• Carpenter Technology Shifts to Bull Market: Get the Latest Upgrades
• Immunic, Inc. Delivers Positive Q3 2025 Financial Outcomes
• Critical One Energy's Strategic Hire to Elevate Antimony-Gold Focus
• HLS Therapeutics Reports Strong Growth in Q3 2025 Results
• Alliance Creative Group Unveils Q3 Results and Future Growth Plans
• Brookfield Corporation Shines with Stellar Q3 Financial Performance
• Brookfield Wealth Solutions Shares Important Q3 Financials
• Pelthos Therapeutics Reports Strong Q3 2025 Performance Highlights
• Exploring Bilibili's Surge: Engagement and Revenue Growth
• Dillard's Inc Achieves Growth Amid Third Quarter Challenges
• Protalix BioTherapeutics Sees Revenue Growth and Future Potential
• Alliance Creative Group's Strategic Growth and Financial Insights
• Brookfield Wealth Solutions Reports Strong Third Quarter Gains
• Quhuo Strengthens International Trade with Blockchain Innovations
• Revolutionizing Haircare: Neutrogena® and OGX® Innovations
• Brightstar Lottery to Launch Innovative Instant Ticket Games
• Tradr Unveils New Leveraged ETFs Focused on Tech Innovations
• Protalix BioTherapeutics Shares Q3 2025 Financial Insights
• Duncan Regional Hospital Pioneers Infusion Technology with BD
• Pelthos Therapeutics Reports Strong Q3 2025 Performance
• Brookfield Corporation Delivers Impressive Third Quarter Growth
• Exploring the Timeless Lessons of Tiangong Kaiwu Culture
• Castellum, Inc. Achieves $2 Million Debt Elimination Milestone
• RecycLiCo Advances Growth Strategies at Global Conference
• Bitfarms Reveals Ambitious Transition to HPC and AI Workloads
• Day One Biopharmaceuticals Closes In on Strategic Acquisition
• EnviroGold Global's Phase 3 Results Showcase Remarkable Advances
• Day One Biopharmaceuticals to Acquire Mersana Therapeutics
• Exciting Innovations from Dassault Aviation at Airshow
• Apple's New Feature: Digital Passport on Your iPhone
• Strategic Growth: Americas Gold and Silver's Acquisition Plans
• Grab and WeRide Secure Approval for Innovative AV Testing
• Beacon Biosignals Secures $86M for Revolutionary AI Innovations
• Analyst Critiques Oracle's AI Strategy: A Risky Business Model